Danaparoid and disease progression Patient Reports February 12, 2012

Danaparoid Side Effects Report #5093416-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Aug 22, 2006. Female patient, 78 years of age, was diagnosed with phlebitis deep, thrombophlebitis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with PHENOBARBITAL. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5033185-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Female patient, 89 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, gastric haemorrhage, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, GABEXATE MESILATE, DOPAMINE, CARPERITIDE, INSULIN, FUROSEMIDE, MIDAZOLAM, CEFOTIAM HYDROCHLORIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5124738-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHAGE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5024706-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, CLINDAMYCIN, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SILVELESTAT. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5030495-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHATE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4991406-0
Danaparoid side effect was reported by a Health Professional from AFGHANISTAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5033187-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastrointestinal haemorrhage, haemorrhage subcutaneous, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5134219-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia. Danaparoid dosage: unknown. During the same period patient was treated with PENICILLIN G POTASSIUM. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5113484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, postoperative wound infection. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, SIVELESTAT, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5027823-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, operative haemorrhage, postoperative wound infection. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, SIVELESTAT, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5030651-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, disease progression, disseminated intravascular coagulation, hepatic function abnormal, malnutrition, postoperative infection, renal impairment, wound haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5056239-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #5062425-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.


Danaparoid Side Effects Report #5076374-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 27, 2006. Male patient, 70 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, haemorrhagic diathesis, hepatic ischaemia, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with CEFPIROME SULPHATE, ISEPAMICIN SULPHATE, MINOPHAGEN C, GLUTATHIONE, MIDAZOLAM HYDROCHLORIDE, VECURONIUM BROMIDE, DOPAMINE, VERAPAMIL HYDROCHLORIDE. Patient recovered.

Danaparoid Side Effects Report #5030481-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with PENICILLIN G POTASSIUM. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5124726-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5123364-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, platelet count increased, protein total decreased, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.


Danaparoid Side Effects Report #5030494-2
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, renal impairment, sepsis , thermal burn. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #5024833-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, TIENAM, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #6130925-0
Danaparoid side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 18, 2009. Male patient, 44 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, heparin-induced thrombocytopenia. Danaparoid dosage: unknown. Patient died.